Hsp90β-selective inhibitors NDNB1 and NDNB1182 exhibit low or submicromolar antiproliferative IC50 values against TNBC cell lines with a 2-5-fold selectivity for cancer cells. This evidence concerns the gene HSP90AB1 and cancer.